Bio-Techne Corporation (TECH)
TECH Stock Price Chart
Explore Bio-Techne Corporation interactive price chart. Choose custom timeframes to analyze TECH price movements and trends.
TECH Company Profile
Discover essential business fundamentals and corporate details for Bio-Techne Corporation (TECH) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
9 Feb 1989
Employees
3.10K
Website
https://www.bio-techne.comCEO
Kim Kelderman
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures biological reagents used in various aspects of life science research, diagnostics, and cell and gene therapy, such as cytokines and growth factors, antibodies, small molecules, tissue culture sera, and cell selection technologies. This segment also offers proteomic analytical tools for automated western blot and multiplexed ELISA workflow consists of manual and automated protein analysis instruments and immunoassays for use in quantifying proteins in various biological fluids. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits for research and clinical applications; and sells products for genetic carrier screening, oncology diagnostics, molecular controls, and research, as well as instruments and process control products for hematology, blood chemistry and gases, and coagulation controls and reagents used in various diagnostic applications. It offers its products under R&D Systems, Tocris Biosciences, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Exosome Diagnostics, and Asuragen brands. The company was formerly known as Techne Corporation and changed its name to Bio-Techne Corporation in November 2014. Bio-Techne Corporation was founded in 1976 and is headquartered in Minneapolis, Minnesota.
TECH Financial Timeline
Browse a chronological timeline of Bio-Techne Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 3 Feb 2026
Upcoming earnings on 29 Oct 2025
EPS estimate is $0.42.
Earnings released on 6 Aug 2025
EPS came in at $0.53 surpassing the estimated $0.50 by +6.00%, while revenue for the quarter reached $316.96M , beating expectations by +7.58%.
Dividend declared on 6 Aug 2025
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 29 Aug 2025.
Earnings released on 7 May 2025
EPS came in at $0.56 surpassing the estimated $0.51 by +9.80%, while revenue for the quarter reached $316.18M , missing expectations by -2.85%.
Dividend declared on 7 May 2025
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 30 May 2025.
Earnings released on 5 Feb 2025
EPS came in at $0.42 surpassing the estimated $0.38 by +10.53%, while revenue for the quarter reached $297.03M , missing expectations by -6.46%.
Dividend declared on 5 Feb 2025
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 28 Feb 2025.
Earnings released on 30 Oct 2024
EPS came in at $0.42 surpassing the estimated $0.38 by +10.53%, while revenue for the quarter reached $289.50M , beating expectations by +3.30%.
Dividend declared on 30 Oct 2024
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 22 Nov 2024.
Earnings released on 7 Aug 2024
EPS came in at $0.49 falling short of the estimated $0.49 by -0.99%, while revenue for the quarter reached $306.10M , missing expectations by -0.13%.
Dividend declared on 7 Aug 2024
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 30 Aug 2024.
Earnings released on 1 May 2024
EPS came in at $0.48 surpassing the estimated $0.46 by +4.35%, while revenue for the quarter reached $303.43M , missing expectations by -0.86%.
Dividend declared on 1 May 2024
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 24 May 2024.
Earnings released on 1 Feb 2024
EPS came in at $0.40 falling short of the estimated $0.42 by -4.76%, while revenue for the quarter reached $272.60M , missing expectations by -1.86%.
Dividend declared on 1 Feb 2024
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 26 Feb 2024.
Earnings released on 31 Oct 2023
EPS came in at $0.41 falling short of the estimated $0.44 by -6.82%, while revenue for the quarter reached $276.94M , missing expectations by -4.96%.
Dividend declared on 31 Oct 2023
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 24 Nov 2023.
Earnings released on 8 Aug 2023
EPS came in at $0.55 matching the estimated $0.55, while revenue for the quarter reached $301.32M , missing expectations by -1.93%.
Dividend declared on 8 Aug 2023
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 1 Sept 2023.
Earnings released on 3 May 2023
EPS came in at $0.53 matching the estimated $0.53, while revenue for the quarter reached $294.15M , missing expectations by -0.85%.
Dividend declared on 3 May 2023
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 26 May 2023.
Earnings released on 2 Feb 2023
EPS came in at $0.47 falling short of the estimated $0.49 by -4.08%, while revenue for the quarter reached $271.58M , missing expectations by -5.96%.
Dividend declared on 2 Feb 2023
A dividend of $0.08 per share was announced, adjusted to $0.08. The dividend was paid on 27 Feb 2023.
Stock split effective on 30 Nov 2022
Shares were split 4 : 1 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 1 Nov 2022
EPS came in at $0.45 falling short of the estimated $0.59 by -23.73%, while revenue for the quarter reached $269.66M , missing expectations by -4.32%.
Dividend declared on 1 Nov 2022
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 28 Nov 2022.
Earnings released on 4 Aug 2022
EPS came in at $0.51 falling short of the estimated $0.52 by -1.92%, while revenue for the quarter reached $288.23M , beating expectations by +0.53%.
Dividend declared on 4 Aug 2022
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 29 Aug 2022.
Earnings released on 4 May 2022
EPS came in at $0.54 surpassing the estimated $0.50 by +8.00%, while revenue for the quarter reached $290.38M , beating expectations by +3.98%.
Dividend declared on 4 May 2022
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 27 May 2022.
Earnings released on 1 Feb 2022
EPS came in at $0.47 surpassing the estimated $0.45 by +4.44%, while revenue for the quarter reached $269.28M , beating expectations by +1.06%.
Dividend declared on 1 Feb 2022
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 25 Feb 2022.
Earnings released on 2 Nov 2021
EPS came in at $0.46 surpassing the estimated $0.43 by +6.98%, while revenue for the quarter reached $257.72M , beating expectations by +1.95%.
Dividend declared on 2 Nov 2021
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 26 Nov 2021.
Earnings released on 5 Aug 2021
EPS came in at $0.47 surpassing the estimated $0.42 by +11.90%, while revenue for the quarter reached $259.03M , meeting expectations.
Dividend declared on 5 Aug 2021
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 27 Aug 2021.
Earnings released on 6 May 2021
EPS came in at $0.45 surpassing the estimated $0.38 by +18.42%, while revenue for the quarter reached $243.55M , beating expectations by +6.72%.
Dividend declared on 6 May 2021
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 28 May 2021.
Earnings released on 2 Feb 2021
EPS came in at $0.41 surpassing the estimated $0.34 by +20.59%, while revenue for the quarter reached $224.25M , beating expectations by +8.61%.
Dividend declared on 2 Feb 2021
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 26 Feb 2021.
Earnings released on 5 Nov 2020
EPS came in at $0.36 surpassing the estimated $0.29 by +24.14%, while revenue for the quarter reached $204.20M , beating expectations by +31.19%.
Dividend declared on 5 Nov 2020
A dividend of $0.32 per share was announced, adjusted to $0.08. The dividend was paid on 27 Nov 2020.
TECH Stock Performance
Access detailed TECH performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.